AQUABOUNTY TECHNOLOGIES INC (AQB): Entry into a Material Definitive Agreement
AQUABOUNTY TECHNOLOGIES INC (AQB) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. EX-10.2 4 aqb-20260625xex10_2.htm EX-10.2 Ex 10.2 Placement Agency Agreement 06-25-2026 Exhibit 10.2 PLACEMENT AGENCY AGREEMENT June 2 5 , 2026 Univest Securities, LLC 75 Rockefeller Plaza, Suite 18C New York, NY, 10019 Ladies and Gentlemen: This letter (the “ Agreement ” ) const
How this was made
The 30-second read
Why it matters
The company’s agreement contemplates a private placement of newly created Series B convertible preferred stock for cash proceeds up to $2.3M, with a 7% cash placement fee to the agent. This can influence valuation via dilution expectations and financing risk, but the excerpt lacks final issuance economics and closing certainty.
Market read
A new equity-linked financing agreement is disclosed, creating a near-term trading catalyst tied to dilution/closing expectations and any subsequent disclosure of final terms.
What to watch
Traders will need the final Purchase Agreement terms (conversion price/ratio, protective provisions, and whether common stock issuance triggers Nasdaq approval issues) to gauge dilution and overhang accurately.
Background
The SEC 8-K reports Item 1.01 (entry into a material definitive agreement) and Item 3.02 (unregistered sales of equity securities), including an exhibit describing a placement agency agreement.
Ticker impact
AquaBounty entered a placement-agency agreement for a private offering of up to $2.3M in Series B convertible preferred stock.
Near-term: modest downside risk from dilution/financing overhang; direction depends on whether the placement closes and on conversion terms.
The 8-K is a primary disclosure of a definitive agreement for a private placement, but the excerpt does not include final pricing, conversion ratio, or investor details—key drivers of magnitude.
Market effects
Adds to the broader pattern of biotech/alt-aquaculture firms using equity-linked financings to fund operations, which can affect peer sentiment around capital needs.
Primarily impacts US small-cap risk appetite for micro/small-cap growth issuers.
Limited; the disclosure is company-specific with no stated cross-border deal terms in the excerpt.
Counterpoint
If the Series B converts at favorable terms or is structured to minimize dilution, the placement could be viewed as a liquidity backstop rather than a bearish overhang.
Key entities
- companyAquaBounty Technologies, Inc.
Subject of the 8-K; entered into a placement agency agreement for a private offering of Series B convertible preferred stock.
- placement_agentUnivest Securities, LLC
Placement agent under the agreement; receives a 7% cash fee on gross proceeds actually received.
- securitySeries B Convertible Preferred Stock
Newly created preferred security to be issued in the proposed private placement; conversion may result in common stock issuance.
